Asundexian
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Asundexian, covering 2024-12-09 to 2025-11-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke [Phase 3]